“selecta-biosciences” Archives

in
Entry Author Date Location
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Gene Therapy 2.0: New Startups Aim to Fine-Tune Gene Delivery and Control 01/04/18 Boston
Gilman’s Next CEO Trick: Taming CAR-T Cells With Obsidian 12/06/17 Boston
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Investors Sour on Data Debut For Dimension’s Hemophilia Gene Therapy 01/31/17 Boston
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
Fresh Off ASH Data, Spark Teams With Selecta to Boost Gene Therapies 12/05/16 Boston
Novan Files for IPO to Finance ‘Nitric Oxide on Demand’ Skin Drugs 08/25/16 Raleigh Durham
Gemphire’s Delayed $30M IPO Will Pay for Trials of Cholesterol Drug 08/10/16 Detroit Ann Arbor
Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup 06/30/16 Boston
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More 06/24/16 National
Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case 06/22/16 Boston
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More 09/11/15 Boston
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round 09/08/15 Boston
Selecta Biosciences Receives $38,000,000 Series E Round 09/08/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
Selecta Takes Nanotech to Gene Therapy, Celiac With New Deals 05/13/15 Boston
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer 10/15/14 Boston
Selecta Biosciences Secures $20,000,000 New Funding Round 10/15/14 Boston
Selecta Biosciences Receives $4,450,000 New Funding Round 08/29/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Selecta Biosciences Garners $9,350,000 New Financing 06/18/14 Boston
Page 1 of 2 next page »